{
    "nctId": "NCT06087237",
    "briefTitle": "The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery",
    "officialTitle": "The Efficacy of Pentoxifylline in Reducing Post-surgical Complications in Patients Undergoing Breast Cancer Surgery",
    "overallStatus": "RECRUITING",
    "conditions": "Post-Surgical Complication, Breast Cancer Surgery",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "Postoperative level of pain",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Adult female patients aged 18 to 65 years\n2. Patients completed neoadjuvant chemotherapy cycles and scheduled for breast cancer surgery.\n\nExclusion Criteria:\n\n1. Patients on treatment regimen of phosphodiesterase inhibitors\n2. Patients who are taking antiplatelet or anticoagulant treatment\n3. Patients who are allergic to phosphodiesterase inhibitors\n4. History of recent hemorrhagic events\n5. Active peptic ulcer\n6. History of psychological problems\n7. History of chronic pain management\n8. Pregnancy or breastfeeding",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}